Join
Live feed
·
INSIDERFilingvia Quantisnow
Aeglea BioTherapeutics Inc. logo

SEC Form 4: Hanley Jr. Michael Conick bought $20,022 worth of shares (28,200 units at $0.71), increasing direct ownership by 352% to 36,200 units

ByQuantisnow·Wall Street's wire, on your screen.
AGLE· Aeglea BioTherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGLE (Aeglea BioTherapeutics Inc.) and more on Quantisnow.